Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LTRN US Equity

Lantern Pharma Inc.Health Care · Pharmaceutical Preparations · CIK 1763950 · FY ends Dec 31
$2.49
-0.03 (-1.19%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Empery Asset Management, LPsec.gov ↗
2026-08-038-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-2313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by SATTERFIELD THOMAS A JRsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-23

Every row is a filed document, checked against its EDGAR index.